Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Didier Bouscary, Estelle Saland et al.|Blood|2015Cited by 383
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Nathalie Jacque et al.|Blood|2013Cited by 286
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S. Green, Jérôme Tamburini, Nicolas Chapuis et al.|Blood|2010Cited by 196